What is the current state of research on long-term therapy using PARP inhibitors in patients with BRCA mutations?

Hassan GHAZAL
oncologist, Dubai
CONTINUE READING

What are the key findins of the PATINA trial for patients with hormone receptor-positive, HER2-positive metastatic breast cancer ?

Hassan GHAZAL
oncologist, Dubai
CONTINUE READING

What are the update of DESTINY BREAST 12 in HER2 positive disease with brain metastatis ?

Hassan GHAZAL
oncologist, Dubai
CONTINUE READING

What are the goals of AROME?

Jospeh GLIGOROV
oncologist, Paris, France
CONTINUE READING

Is there a list of essential medications for breast cancer?

Jospeh GLIGOROV
oncologist, Paris, France
CONTINUE READING

Why can breast cancer be a model for cancer research?

Georgia DEMETRIOU
oncologist, Johannesburg, SA
CONTINUE READING

What strategy to use to manage side effects in practice?

Georgia DEMETRIOU
oncologist, Johannesburg, SA
CONTINUE READING

What’s your take on new breast cancer treatments?

Georgia DEMETRIOU
oncologist, Johannesburg, SA
CONTINUE READING

Copyright © 2025 - BCU